MEDIROM Group Reports Q1 2026 Results
TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview…
Agomab Announces Results of Annual General Meeting
Antwerp, Belgium, May 27, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”),…
Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions
Data from randomized, double-blind study in 226 adults to be presented as…
Aurora Mobile Limited Announces First Quarter 2026 Unaudited Financial Results
SHENZHEN, China, May 26, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (“Aurora…
Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa
Study met its primary objective demonstrating excellent safety and tolerability, of RESP-X…
Regional Health Properties Reports First Quarter 2026 Results
Reported First Quarter Revenue of $21.2 millionGenerated Adjusted EBITDA from Operations of…
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
- Stenoparib clinical development continues in relapsed small cell lung cancer and,…
Range Impact Reports 1Q 2026 Financial Results
CLEVELAND, OHIO, May 15, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC:…
Constellation Software Inc. Announces Results of Voting for Directors at Annual General Shareholders Meeting
May 15, 2026 20:23 ET | Source: Constellation Software Inc. TORONTO, May…
Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress
Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
